Patients at risk for post-transplant lymphoproliferative disease can be identified in the first months after lung transplantation by quantitative-competitive-EBV-PCR.
University Hospital Groningen, Groningen, The Netherlands
E A.
EA
Verschuuren
S
S
Stevens
B B.
BB
Hanekamp
C
C
De Boer
M C.
MC
Harmsen
J M.
JM
Middeldorp
G
G
Koeter
T H.
TH
The
W
W
Van Der Bij